Cargando…

ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis

Diffuse intrinsic pontine glioma (DIPG) is an incurable pediatric brain tumor, with approximately 25% of DIPGs harboring activating ACVR1 mutations that commonly co-associate with H3.1K27M mutations. Here we show that in vitro expression of ACVR1 R206H with and without H3.1K27M upregulates mesenchym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoeman, Christine M., Cordero, Francisco J., Hu, Guo, Misuraca, Katie, Romero, Megan M., Cardona, Herminio J., Nazarian, Javad, Hashizume, Rintaro, McLendon, Roger, Yu, Paul, Procissi, Daniele, Gadd, Samantha, Becher, Oren J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399349/ https://www.ncbi.nlm.nih.gov/pubmed/30833574 http://dx.doi.org/10.1038/s41467-019-08823-9

Ejemplares similares

Pre-Clinical Models of Diffuse Intrinsic Pontine Glioma
por: Misuraca, Katherine L., et al.
Publicado: (2015)

CDK4/6 and PDGFRA Signaling as Therapeutic Targets in Diffuse Intrinsic Pontine Glioma
por: Hoeman, Christine, et al.
Publicado: (2018)

DIPG-51. ACVR1 MUTATIONS PROMOTE TUMOR GROWTH IN MODELS OF DIFFUSE INTRINSIC PONTINE GLIOMA
por: Adorno, Jennifer Ocasio, et al.
Publicado: (2020)

Modeling the ACVR1(R206H) mutation in human skeletal muscle stem cells
por: Barruet, Emilie, et al.
Publicado: (2021)

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
por: Buczkowicz, Pawel, et al.
Publicado: (2014)

Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma
por: Cao, Hongnan, et al.
Publicado: (2020)

Pathogenic ACVR1(R206H) activation by Activin A‐induced receptor clustering and autophosphorylation
por: Ramachandran, Anassuya, et al.
Publicado: (2021)

DDEL-11. CONVECTION-ENHANCED DELIVERY OF EZH2 INHIBITOR FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA
por: Sasaki, Takahiro, et al.
Publicado: (2020)

A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell‐of‐origin dependent effects of H3K27M
por: Tomita, Yusuke, et al.
Publicado: (2022)

ACVR1(R206H) FOP mutation alters mechanosensing and tissue stiffness during heterotopic ossification
por: Haupt, Julia, et al.
Publicado: (2019)

AAV-Mediated Targeting of the Activin A-ACVR1(R206H) Signaling in Fibrodysplasia Ossificans Progressiva
por: Yang, Yeon-Suk, et al.
Publicado: (2023)

A High-Throughput In Vitro Drug Screen in a Genetically Engineered Mouse Model of Diffuse Intrinsic Pontine Glioma Identifies BMS-754807 as a Promising Therapeutic Agent
por: Halvorson, Kyle G., et al.
Publicado: (2015)

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
por: Taylor, Kathryn R, et al.
Publicado: (2014)

HGG-01. A novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of PRC2 target genes and promotion of the NOTCH pathway
por: Abdallah, Aalaa, et al.
Publicado: (2022)

A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells()()
por: Misuraca, Katherine L., et al.
Publicado: (2016)

DIPG-44. A GAIN OF FUNCTION Ezh2 MUTATION DELAYS DIFFUSE INTRINSIC PONTINE GLIOMA PROGRESSION
por: Dhar, Swati, et al.
Publicado: (2020)

Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma
por: HASHIZUME, Rintaro
Publicado: (2017)

Prenatal overexpression of platelet‐derived growth factor receptor A results in central nervous system hypomyelination
por: Cardona, Herminio Joey, et al.
Publicado: (2021)

Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1-Mutant Diffuse Intrinsic Pontine Glioma
por: Carvalho, Diana M., et al.
Publicado: (2022)

Patient-derived Tumor Models for Diffuse Intrinsic Pontine Gliomas
por: Hashizume, Rintaro, et al.
Publicado: (2017)

Novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of Hoxa cluster genes and promotion of neuronal lineage
por: Abdallah, Aalaa S, et al.
Publicado: (2023)

Patients with ACVR1(R206H) mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva
por: Kou, Samuel, et al.
Publicado: (2020)

CDK4/6 and diffuse intrinsic pontine glioma - Evaluate at diagnosis?
por: Becher, Oren J.
Publicado: (2019)

DIPG-06. PRECLINICAL EVALUATION OF A NOVEL ACVR1 INHIBITOR IN DIFFUSE INTRINSIC PONTINE GLIOMAS
por: Kumar, Shiva Senthil, et al.
Publicado: (2023)

The emerging role of NG2 in pediatric diffuse intrinsic pontine glioma
por: Yadavilli, Sridevi, et al.
Publicado: (2015)

Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma
por: Zhao, Guisheng, et al.
Publicado: (2022)

DIPG-03. THERAPEUTIC TARGETING OF TRANSCRIPTIONAL ELONGATION IN DIFFUSE INTRINSIC PONTINE GLIOMA
por: Katagi, Hiroaki, et al.
Publicado: (2020)

A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
por: Dhar, Swati, et al.
Publicado: (2022)

ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma
por: Carvalho, Diana, et al.
Publicado: (2019)

DIPG-24. BRD4 INHIBITION AS A RADIOSENSITIZER THROUGH BLOCKING DNA REPAIR FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA
por: Watanabe, Jun, et al.
Publicado: (2023)

Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma
por: An, Shejuan, et al.
Publicado: (2020)

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B
por: Olsen, Oddrun Elise, et al.
Publicado: (2015)

Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications
por: Buczkowicz, Pawel, et al.
Publicado: (2014)

Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole‐Exome Sequencing in a Patient with Delayed‐Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1(R206H) ‐Specific Human Cellular and Zebrafish Models
por: Wentworth, Kelly L., et al.
Publicado: (2022)

ACVR1 Function in Health and Disease
por: Valer, José Antonio, et al.
Publicado: (2019)

Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022)

Characterization of Fibrodysplasia Ossificans Progessiva relevant Acvr1/Acvr2 Activin receptors in medaka (Oryzias latipes)
por: Trumpp, Michael, et al.
Publicado: (2023)

The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling
por: Barruet, Emilie, et al.
Publicado: (2016)

Differential Expression of Wilms’ Tumor Protein in Diffuse Intrinsic Pontine Glioma
por: Lee, Sulgi, et al.
Publicado: (2019)

MODL-12. DEVELOPMENT OF A NOVEL IMMUNOCOMPETENT MOUSE MODEL FOR DIFFUSE INTRINSIC PONTINE GLIOMA
por: Seblani, Maggie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p9ia6ak3u8v249tdglr9tsf8ls